AMP Capital Investors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,914
Closed -$413K 443
2021
Q3
$413K Buy
+6,914
New +$435K ﹤0.01% 984
2020
Q2
Sell
-5,028
Closed -$250K 1205
2020
Q1
$250K Buy
+5,028
New +$290K ﹤0.01% 1012
2019
Q3
Sell
-11,588
Closed -$571K 1198
2019
Q2
$571K Sell
11,588
-880
-7% -$42.7K ﹤0.01% 969
2019
Q1
$581K Hold
12,468
﹤0.01% 939
2018
Q4
$608K Buy
+12,468
New +$709K ﹤0.01% 921
2018
Q3
Sell
-14,075
Closed -$758K 1162
2018
Q2
$758K Sell
14,075
-17,681
-56% -$884K ﹤0.01% 929
2018
Q1
$1.44M Buy
+31,756
New +$1.36M 0.01% 818
2017
Q3
Sell
-12,319
Closed -$476K 1147
2017
Q2
$476K Sell
12,319
-754
-6% -$27.6K ﹤0.01% 987
2017
Q1
$443K Buy
+13,073
New +$429K ﹤0.01% 1000
2016
Q2
Sell
-123,940
Closed -$3.68M 1200
2016
Q1
$3.68M Buy
123,940
+11,690
+10% +$323K 0.02% 564
2015
Q4
$3.13M Sell
112,250
-4,816
-4% -$137K 0.02% 611
2015
Q3
$3.52M Buy
117,066
+4,816
+4% +$168K 0.03% 547
2015
Q2
$4.11M Buy
112,250
+89,875
+402% +$3.2M 0.03% 524
2015
Q1
$797K Buy
+22,375
New +$766K ﹤0.01% 938

Other funds holding EHC

AMP Capital Investors's EHC Position: Q4 2021 in Review

AMP Capital Investors sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 6,914 shares — an estimated $413K sold.

AMP Capital Investors first reported a position in EHC in Q1 2015 and held it in 14 quarters. The position peaked at $4.11M in Q2 2015. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

  • AMP Capital Investors reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 6,914 Encompass Health shares in Q4 2021, an estimated $413K.
  • AMP Capital Investors first reported a position in Encompass Health in Q1 2015 and held it in 14 quarters.
  • AMP Capital Investors's Encompass Health position peaked at $4.11M in Q2 2015.
  • 409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.